AEGiS-Chicago Tribune: EDITORIAL: Shalala Punts on a Crucial Call Concerning Needle Exchanges Chicago TribuneImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Click here to return to Chicago Tribune main menu
DonateNow


EDITORIAL: Shalala Punts on a Crucial Call Concerning Needle Exchanges

The Chicago Tribune, 435 North Michigan Avenue, Chicago, IL 60611 - 10 March 1997


Mar. 10--The Feb. 18 memo by Health and Human Services Secretary Donna E. Shalala, forwarding to Congress a report on the latest research on the effectiveness of needle-exchange programs in reducing HIV infections among drug users, is a triumph of pusillanimous politics and double talk over facts and sound public policy.

All the research cited in the report corroborates what already has been known for years: Needle-exchange programs reduce HIV infections and save money. They even encourage a significant percentage of addicts to seek treatment.

Yet Shalala couldn't bring herself to ask Congress to lift its 1992 ban on HHS funding of needle-exchange programs. The ban stands until the Surgeon General -- who reports to Shalala -- vouches to Congress that such programs are safe and effective.

AIDS is spreading faster among intravenous drug users than in any other group. According to a study by the National Academy of Sciences, between 1981 and 1993 the percentage of new HIV infections due to unsafe homosexual sex has dropped from 74 to 47 percent, while those attributable to the use of dirty needles by intravenous drug users has doubled, to 24 percent.

Indeed, despite the recently reported annual decline in AIDS deaths overall, AIDS has become the leading cause of death in the African-American and Hispanic communities, primarily because of drug use and dirty needles. Most tragically, many of the victims are the babies or innocent sex partners of HIV-infected addicts.

Needle-exchange programs work. In a 1993 study by Yale University, they were shown to reduce HIV infections by a third. Another study, funded by the Centers for Disease Control and Prevention, indicated that needle exchanges even worked as a bridge for getting significant numbers of users into rehabilitation.

One of the most persuasive arguments is financial. Some 70 needle-exchange research projects, of varying sizes and uncertain funding, operate mostly in large cities, including Chicago. Their average annual budget comes to approximately $169,000 -- about what it costs to treat just one HIV-infected addict during the course of the disease.

None of the six studies cited in the HHS report found any basis for the fear that needle exchanges encourage drug use.

Yet the argument -- largely symbolic -- against these programs is that it looks incongruous for one branch of the government to "subsidize" drug use, however indirectly, while other agencies wage a multibillion-dollar war against it.

It is Shalala's responsibility to sort out facts from symbols -- and fears from reality -- and argue for sound, effective federal policies. By simply tossing the needle-exchange hot potato back to Congress without comment, she has failed in that role.

-----

FOR ONLINE SERVICES:

Visit the Chicago Tribune on America Online (keyword: TRIBUNE) or the Internet Tribune on the World Wide Web at http://www.chicago.tribune.com/

-----


Keywords: HIV; HOMOSEXUAL

Copyright 1997/The Chicago Tribune. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, The Chicago Tribune, 435 North Michigan Avenue, Chicago, IL 60611.KWDhiv;homosexual
970310
CT970301


Copyright © 1997 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611  http://www.chicagotribune.com

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .